Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
Rigel Pharmaceuticals (NASDAQ: RIGL) closed the day trading at $28.7 down -5.22% from the previous closing price of $30.28. In other words, the price has decreased by -$5.22 from its previous closing price. On the day, 0.76 million shares were traded. RIGL stock price reached its highest trading level at $30.08 during the session, while it also had its lowest trading level at $28.63.
Ratios:
For a better understanding of RIGL, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.75 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.82. For the most recent quarter (mrq), Quick Ratio is recorded 1.90 and its Current Ratio is at 2.02. In the meantime, Its Debt-to-Equity ratio is 0.75 whereas as Long-Term Debt/Eq ratio is at 0.47.
Piper Sandler Downgraded its Overweight to Neutral on June 08, 2022, whereas the target price for the stock was revised from $7 to $1.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 04 ’25 when Schorno Dean L sold 2,036 shares for $20.92 per share. The transaction valued at 42,595 led to the insider holds 58,969 shares of the business.
Schorno Dean L sold 1,734 shares of RIGL for $38,020 on Feb 05 ’25. The EVP & Chief Financial Officer now owns 57,235 shares after completing the transaction at $21.93 per share. On Feb 04 ’25, another insider, Santos David A, who serves as the EVP, Chief Commercial Officer of the company, sold 2,125 shares for $20.92 each. As a result, the insider received 44,457 and left with 53,500 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RIGL now has a Market Capitalization of 543142720 and an Enterprise Value of 467466656. As of this moment, Rigel’s Price-to-Earnings (P/E) ratio for their current fiscal year is 5.30, and their Forward P/E ratio for the next fiscal year is 7.93. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.09. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.92 while its Price-to-Book (P/B) ratio in mrq is 6.28. Its current Enterprise Value per Revenue stands at 1.745 whereas that against EBITDA is 4.368.
Stock Price History:
The Beta on a monthly basis for RIGL is 1.23, which has changed by 0.7478684 over the last 52 weeks, in comparison to a change of 0.15101504 over the same period for the S&P500. Over the past 52 weeks, RIGL has reached a high of $43.72, while it has fallen to a 52-week low of $13.57. The 50-Day Moving Average of the stock is -11.43%, while the 200-Day Moving Average is calculated to be 26.49%.
Shares Statistics:
Over the past 3-months, RIGL traded about 588.16K shares per day on average, while over the past 10 days, RIGL traded about 759470 shares per day. A total of 17.94M shares are outstanding, with a floating share count of 17.45M. Insiders hold about 2.70% of the company’s shares, while institutions hold 77.71% stake in the company. Shares short for RIGL as of 1756425600 were 2005855 with a Short Ratio of 3.74, compared to 1753920000 on 2511219. Therefore, it implies a Short% of Shares Outstanding of 2005855 and a Short% of Float of 11.48.
